and Research Directions: A Scientific Statement From the American Heart Association Prevention, Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who
暂无分享,去创建一个
S. Colan | S. Sallan | J. Steinberger | M. Hudson | L. Constine | J. Wilkinson | S. Lipshultz | E. Herman | K. Oeffinger | D. Hsu | T. Miller | David C. Landy | L. Kremer | M. J. Adams | D. Rosenthal | C. Sable | Gautam K. Singh | Thomas R. Cochran | D. Landy
[1] S. Lipshultz,et al. Sex-related Differences in Mast Cell Activity and Doxorubicin Toxicity , 2014, Toxicologic pathology.
[2] S. Lipshultz,et al. Treatment-related cardiotoxicity in survivors of childhood cancer , 2013, Nature Reviews Clinical Oncology.
[3] S. Lipshultz,et al. Cardiotoxicity in childhood cancer survivors: A problem with long‐term consequences in need of early detection and prevention , 2013, Pediatric blood & cancer.
[4] S. Lipshultz,et al. An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies , 2013, Expert opinion on pharmacotherapy.
[5] S. Lipsitz,et al. Dietary Quality, Caloric Intake, and Adiposity of Childhood Cancer Survivors and Their Siblings: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study , 2013, Nutrition and cancer.
[6] H. Caron,et al. A worldwide collaboration to harmonize guidelines for the long‐term follow‐up of childhood and young adult cancer survivors: A report from the international late effects of Childhood Cancer Guideline Harmonization Group , 2013, Pediatric blood & cancer.
[7] Angela M. Miller,et al. Exercise capacity in long‐term survivors of pediatric cancer: An analysis from the cardiac risk factors in childhood cancer survivors study , 2013, Pediatric blood & cancer.
[8] R. Steiner. Increasing exercise in long‐term survivors of pediatric cancer and their siblings: Should treatment be a family affair? , 2013, Pediatric blood & cancer.
[9] S. Lipsitz,et al. Cranial Irradiation as an Additional Risk Factor for Anthracycline Cardiotoxicity in Childhood Cancer Survivors: An Analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study , 2013, Pediatric Cardiology.
[10] J. Wilkinson,et al. Screening for long-term cardiac status during cancer treatment. , 2012, Circulation. Cardiovascular imaging.
[11] S. Lipshultz,et al. Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. , 2012, Future cardiology.
[12] J. Wilkinson,et al. Can the consequences of universal cholesterol screening during childhood prevent cardiovascular disease and thus reduce long-term health care costs? , 2012, Pediatric endocrinology reviews : PER.
[13] M. Aznar,et al. Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma. , 2012, International journal of radiation oncology, biology, physics.
[14] S. Lipshultz,et al. Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] S. Sallan,et al. Cardiac Failure 30 Years After Treatment Containing Anthracycline for Childhood Acute Lymphoblastic Leukemia , 2012, Journal of pediatric hematology/oncology.
[16] Olivier Laurent,et al. Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality Risks , 2012, Environmental health perspectives.
[17] K. Krull,et al. Perceived positive impact of cancer among long‐term survivors of childhood cancer: a report from the childhood cancer survivor study , 2012, Psycho-oncology.
[18] S. Lipshultz,et al. Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer , 2012 .
[19] L. Tapsell,et al. Dietary intake after treatment in child cancer survivors , 2012, Pediatric blood & cancer.
[20] C. Koning,et al. High risk of symptomatic cardiac events in childhood cancer survivors. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Steinberger,et al. Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation , 2012 .
[22] S. Lipsitz,et al. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] S. Lipsitz,et al. Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] J. Steinberger,et al. Cardiovascular risk and insulin resistance in childhood cancer survivors. , 2012, The Journal of pediatrics.
[25] C. Pui,et al. Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies , 2012, Pediatric blood & cancer.
[26] G. Armstrong,et al. Physical activity among adult survivors of childhood lower-extremity sarcoma , 2012, Journal of Cancer Survivorship.
[27] S. Lipsitz,et al. Aggregating traditional cardiovascular disease risk factors to assess the cardiometabolic health of childhood cancer survivors: an analysis from the Cardiac Risk Factors in Childhood Cancer Survivors Study. , 2012, American heart journal.
[28] A. Varan,et al. Tissue doppler evaluation of systolic and diastolic cardiac functions in long‐term survivors of Hodgkin lymphoma , 2012, Pediatric blood & cancer.
[29] R. Ross,et al. Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia , 2012, Pediatric blood & cancer.
[30] C. Sklar,et al. Therapy for pediatric brain tumors and the risk of growth hormone deficiency. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] T. Merchant,et al. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] K. Kodama,et al. Radiation Dose Associated with Renal Failure Mortality: A Potential Pathway to Partially Explain Increased Cardiovascular Disease Mortality Observed after Whole-Body Irradiation , 2011, Radiation research.
[33] Jiaquan Xu,et al. Deaths: final data for 2008. , 2011, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[34] S. Meikle,et al. Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[35] W. Demark-Wahnefried,et al. Health behaviors and weight status of childhood cancer survivors and their parents: similarities and opportunities for joint interventions. , 2011, Journal of the American Dietetic Association.
[36] J. Ornato,et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. , 2011, JAMA.
[37] M. Pulsipher,et al. National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[38] K. Ness,et al. Exercise Interventions in Children with Cancer: A Review , 2011, International journal of pediatrics.
[39] B. Rosenzweig,et al. A Multifaceted Evaluation of Imatinib-induced Cardiotoxicity in the Rat , 2011, Toxicologic pathology.
[40] M. Heymans,et al. Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch National Registry of Growth Hormone Treatment in adults. , 2011, The Journal of clinical endocrinology and metabolism.
[41] B. Rensing,et al. Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease. , 2011, Cancer treatment reviews.
[42] G. Armstrong,et al. Occurrence of multiple subsequent neoplasms in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] T. D. de Backer,et al. CARDIOVASCULAR TOXICITY OF CANCER TREATMENT , 2011, Acta clinica Belgica.
[44] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[45] S. Baruchel,et al. Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study , 2011, Clinical Cancer Research.
[46] H. Dickinson,et al. Cardioprotective interventions for cancer patients receiving anthracyclines. , 2011, The Cochrane database of systematic reviews.
[47] J. Jassem,et al. Cardiovascular effects of systemic cancer treatment. , 2011, Cancer treatment reviews.
[48] D. Lefkopoulos,et al. Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood. , 2011, International journal of radiation oncology, biology, physics.
[49] D. Neuberg,et al. The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: a report from the Dana-Farber Cancer Institute ALL Consortium. , 2011, European journal of cancer.
[50] J. Fulbright. Review of Cardiotoxicity in Pediatric Cancer Patients: During and after Therapy , 2011, Cardiology research and practice.
[51] Randolph P. Martin,et al. Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. , 2011, The American journal of cardiology.
[52] J. Grill,et al. Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. , 2011, Brain : a journal of neurology.
[53] S. Bakhshi,et al. 5-Fluorouracil-induced acute dilated cardiomyopathy in a pediatric patient. , 2011, Journal of pediatric hematology/oncology.
[54] P. Auquier,et al. Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia , 2011 .
[55] Benjamin Willis,et al. Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study. , 2011, Journal of the American College of Cardiology.
[56] Jens-Uwe Voigt,et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients. , 2011, International journal of radiation oncology, biology, physics.
[57] N. Weissman,et al. A suggested roadmap for cardiovascular ultrasound research for the future. , 2011, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[58] W. Landier,et al. The perceived impact of cancer on quality of life for post-treatment survivors of childhood cancer , 2011, Quality of Life Research.
[59] M. Beer,et al. Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease. , 2011, International journal of radiation oncology, biology, physics.
[60] T. Shimizu,et al. High incidence of fatty liver and insulin resistance in long-term adult survivors of childhood SCT , 2011, Bone Marrow Transplantation.
[61] D. Friedman,et al. Body mass index and blood pressure changes over the course of treatment of pediatric acute lymphoblastic leukemia , 2011, Pediatric blood & cancer.
[62] S. Lipshultz,et al. Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines , 2011, Cardiology research and practice.
[63] S. Lipshultz,et al. Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer , 2011, Pediatric Cardiology.
[64] G. Pongiglione,et al. Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors , 2011, Pediatric blood & cancer.
[65] R. Pötter,et al. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for hodgkin disease in children and adolescents: Report from the longitudinal GPOH follow‐up project of the German–Austrian DAL‐HD studies , 2010, Pediatric blood & cancer.
[66] D. Friedman,et al. Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[67] P. McAuley,et al. Cardiorespiratory fitness, adiposity, and all-cause mortality in women. , 2010, Medicine and science in sports and exercise.
[68] Pamela K Woodard,et al. Accuracy and reproducibility of strain by speckle tracking in pediatric subjects with normal heart and single ventricular physiology: a two-dimensional speckle-tracking echocardiography and magnetic resonance imaging correlative study. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[69] J. Kastelein,et al. Increased prevalence of risk factors for cardiovascular disease in long‐term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy , 2010, Pediatric blood & cancer.
[70] S. Lipsitz,et al. Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. , 2010, The Lancet. Oncology.
[71] A. Allegra,et al. Cardiac Involvement in Patients With Hematologic Malignancies , 2010, Journal of Investigative Medicine.
[72] P. Anderson,et al. Can Anthracycline Therapy for Pediatric Malignancies Be Less Cardiotoxic? , 2010, Current oncology reports.
[73] Giuseppe Curigliano,et al. Cardiac toxicity from systemic cancer therapy: a comprehensive review. , 2010, Progress in cardiovascular diseases.
[74] D. Hsu,et al. BNP Levels Predict Outcome in Pediatric Heart Failure Patients: Post Hoc Analysis of the Pediatric Carvedilol Trial , 2010, Circulation. Heart failure.
[75] J. Björk,et al. Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia. , 2010, The Journal of clinical endocrinology and metabolism.
[76] N. Artinian,et al. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. , 2010, Circulation.
[77] M. Hauptmann,et al. Cardiac function in 5-year survivors of childhood cancer: a long-term follow-up study. , 2010, Archives of internal medicine.
[78] S. Lipsitz,et al. Characteristics and Determinants of Adiposity in Pediatric Cancer Survivors , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[79] J. Neglia,et al. Health and risk behaviors in survivors of childhood acute myeloid leukemia: A report from the Children's Oncology Group , 2010, Pediatric blood & cancer.
[80] A. Craft,et al. Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or dose , 2010, Pediatric blood & cancer.
[81] S. Pakakasama,et al. Impaired Glucose Tolerance and Insulin Resistance in Survivors of Childhood Acute Lymphoblastic Leukemia: Prevalence and Risk Factors , 2010, Journal of pediatric hematology/oncology.
[82] B. Rosenzweig,et al. Early alterations in heart gene expression profiles associated with doxorubicin cardiotoxicity in rats , 2010, Cancer Chemotherapy and Pharmacology.
[83] F. Pınarlı,et al. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion. , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[84] L. Sharp,et al. Diet and Physical Activity in Childhood Cancer Survivors: A Review of the Literature , 2010, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[85] K. Ness,et al. Physical performance limitations among adult survivors of childhood brain tumors , 2010, Cancer.
[86] P. Lähteenmäki,et al. Physical activity and fitness in adolescent and young adult long-term survivors of childhood acute lymphoblastic leukaemia , 2010, Journal of cancer survivorship : research and practice.
[87] S. Uijtdehaage,et al. Prevalence and Predictors of Posttraumatic Stress Disorder in Adult Survivors of Childhood Cancer , 2010, Pediatrics.
[88] K. Wolin,et al. Exercise in adult and pediatric hematological cancer survivors: an intervention review , 2010, Leukemia.
[89] B. Storer,et al. Hypertension in long-term survivors of pediatric hematopoietic cell transplantation. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[90] S. Lipshultz,et al. Cardiotoxicity after childhood cancer: beginning with the end in mind. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[91] Lingling Zhu,et al. Single-agent arsenic trioxide in the treatment of children with newly diagnosed acute promyelocytic leukemia. , 2010, Blood.
[92] H. Caron,et al. Hypertension in long-term survivors of childhood cancer: a nested case-control study. , 2010, European journal of cancer.
[93] A. Varan,et al. Evaluation of coronary artery disease by computed tomography angiography in patients treated for childhood Hodgkin's lymphoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[94] L. Diller,et al. Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] Mark A Sussman,et al. Juvenile Exposure to Anthracyclines Impairs Cardiac Progenitor Cell Function and Vascularization Resulting in Greater Susceptibility to Stress-Induced Myocardial Injury in Adult Mice , 2010, Circulation.
[96] S. De Flora,et al. Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention , 2010, Journal of the National Cancer Institute.
[97] K. Ness,et al. Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer—A Report from the Childhood Cancer Survivor Study , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[98] M. Hudson,et al. Survivorship: childhood cancer survivors. , 2009, Primary care.
[99] K. Yeom,et al. Cerebrovascular disease in childhood cancer survivors , 2009, Neurology.
[100] A. Dipchand,et al. Outcome of pediatric patients with dilated cardiomyopathy listed for transplant: a multi-institutional study. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[101] L. Cozzi,et al. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study. , 2009, International journal of radiation oncology, biology, physics.
[102] A. Craft,et al. Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factors. , 2009, European journal of cancer.
[103] R. Pieters,et al. Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[104] J. Svensson,et al. Safety aspects of GH replacement. , 2009, European journal of endocrinology.
[105] H. Azim,et al. Trastuzumab versus lapatinib: the cardiac side of the story. , 2009, Cancer treatment reviews.
[106] S. Grundy,et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.
[107] L. Robinson,et al. Anti-Smoking Communication to Preadolescents With and Without a Cancer Diagnosis: Parents and Health Care Providers as Important Communicators , 2009, Children's health care : journal of the Association for the Care of Children's Health.
[108] C. Tu,et al. Trastuzumab (Herceptin)-associated cardiomyopathy presented as new onset of complete left bundle-branch block mimicking acute coronary syndrome: a case report and literature review. , 2009, The American journal of emergency medicine.
[109] D. Mulrooney,et al. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[110] C. Sklar,et al. Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study , 2009, Bone Marrow Transplantation.
[111] L. Saccá,et al. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. , 2009, The Journal of clinical endocrinology and metabolism.
[112] Jong Hun Park,et al. Cardiac Functional Evaluation Using Vector Velocity Imaging After Chemotherapy Including Anthracyclines in Children With Cancer , 2009, Korean circulation journal.
[113] L. Robison,et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. , 2009, Archives of internal medicine.
[114] T. Marwick,et al. Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab. , 2009, American heart journal.
[115] R. Ross,et al. Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[116] H. Kal,et al. Induction of severe cataract and late renal dysfunction following total body irradiation: dose-effect relationships. , 2009, Anticancer research.
[117] A. D. Van den Abbeele,et al. Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib , 2009, Pediatric blood & cancer.
[118] G. Rosner,et al. Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study , 2009, Cancer Chemotherapy and Pharmacology.
[119] E. Yeh,et al. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. , 2009, Journal of the American College of Cardiology.
[120] Yasuo Ohashi,et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. , 2009, JAMA.
[121] P. Nathan,et al. Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[122] G. Armstrong,et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] Marilyn Stovall,et al. Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[124] M. Piccart-Gebhart,et al. Cardiac toxicity with anti-HER-2 therapies-what have we learned so far? , 2009, Targeted Oncology.
[125] S. Baruchel,et al. In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model. , 2009, Neoplasia.
[126] J. Dixon,et al. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[127] G. Armstrong,et al. Predictors of inactive lifestyle among adult survivors of childhood cancer , 2009, Cancer.
[128] E. Feuer,et al. Long-Term Survivors of Childhood Cancers in the United States , 2009, Cancer Epidemiology Biomarkers & Prevention.
[129] D. Jassal,et al. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[130] E. D. de Vries,et al. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. , 2009, The Lancet. Oncology.
[131] K. Muroya,et al. Unfavorable lipoprotein profile in childhood cancer survivors with suprasellar brain tumors—a high Apo B level and increased small dense LDL-cholesterol , 2009, Child's Nervous System.
[132] B. Popkin,et al. Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, , 2009, Circulation.
[133] A. Heusch,et al. Present Risk of Anthracycline or Radiation-induced Cardiac Sequelae Following Therapy of Malignancies in Children and Adolescents , 2009, Klinische Padiatrie.
[134] D. Green,et al. Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology Group , 2008, Pediatric blood & cancer.
[135] C. Zielinski,et al. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[136] K. Ness,et al. Poor Adherence to Dietary Guidelines Among Adult Survivors of Childhood Acute Lymphoblastic Leukemia , 2008, Journal of pediatric hematology/oncology.
[137] A. Garden,et al. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] A. Ludomirsky,et al. Maturational and growth-related changes in left ventricular longitudinal strain and strain rate measured by two-dimensional speckle tracking echocardiography in healthy pediatric population. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[139] L. Robison,et al. Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[140] Wendy Leisenring,et al. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. , 2008, Journal of the National Cancer Institute.
[141] T. Salmi,et al. Long‐term follow‐up of renal function after high‐dose methotrexate treatment in children , 2008, Pediatric blood & cancer.
[142] M. D. De Bruin,et al. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. , 2008, Journal of the National Cancer Institute.
[143] M. Barrera,et al. Smoking and binge drinking among Canadian survivors of childhood and adolescent cancers: A comparative, population‐based study , 2008, Pediatric blood & cancer.
[144] Narine Sarvazyan,et al. Anthracycline cardiotoxicity: from bench to bedside. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[145] R. Steingart,et al. Coronary artery disease after radiation therapy for Hodgkin's lymphoma: coronary CT angiography findings and calcium scores in nine asymptomatic patients. , 2008, AJR. American journal of roentgenology.
[146] R. Goldsby,et al. Alcohol consumption patterns and risk factors among childhood cancer survivors compared to siblings and general population peers. , 2008, Addiction.
[147] S. Keir,et al. Initial testing (stage 1) of sunitinib by the pediatric preclinical testing program , 2008, Pediatric blood & cancer.
[148] M. Relling,et al. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline‐related congestive heart failure after childhood cancer , 2008, Cancer.
[149] M. Halushka,et al. Heart failure associated with sunitinib malate , 2008, Cancer.
[150] E. Perez,et al. Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials. , 2008, Mayo Clinic proceedings.
[151] S. Palmer,et al. Cardiovascular risk in long‐term survivors of testicular cancer , 2008, Cancer.
[152] J. Triedman,et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.
[153] A. Rogol,et al. Growth hormone deficiency in children , 2008, Pituitary.
[154] B. Drew,et al. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. , 2008, Circulation.
[155] D. Jacobs,et al. Measurement of Insulin Sensitivity in Children , 2008, Diabetes Care.
[156] S. Lipshultz,et al. Cardiometabolic disease in human immunodeficiency virus-infected children. , 2008, Journal of the cardiometabolic syndrome.
[157] D. Neuberg,et al. Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[158] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[159] E. Ford,et al. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999-2002. , 2008, The Journal of pediatrics.
[160] J. Steinberger,et al. Monitoring for Cardiovascular Disease in Survivors of Childhood Cancer: Report From the Cardiovascular Disease Task Force of the Children's Oncology Group , 2008, Pediatrics.
[161] D. Jassal,et al. Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathy , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[162] P. Adamson,et al. Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma. , 2008, Blood.
[163] J. Ross,et al. Trends in childhood cancer incidence in the U.S. (1992–2004) , 2008, Cancer.
[164] F. Stewart,et al. Radiation-induced cardiovascular injury , 2008, Radiation and environmental biophysics.
[165] C. Recklitis,et al. Complementary and alternative therapy use in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study , 2008, Pediatric blood & cancer.
[166] Mark F. Lutz,et al. Monitoring of Anthracycline-Induced Cardiotoxicity , 2008, The Annals of pharmacotherapy.
[167] M. Hudson,et al. Emerging issues in smoking among adolescent and adult cancer survivors , 2007, Cancer.
[168] G. Sutherland,et al. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[169] S. Barlow,et al. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. , 2007, Pediatrics.
[170] D. Friedman,et al. Obesity and hypertension among children after treatment for acute lymphoblastic leukemia , 2007, Cancer.
[171] S. Aggarwal,et al. B‐type natriuretic peptide as a marker for cardiac dysfunction in anthracycline‐treated children , 2007, Pediatric blood & cancer.
[172] M. Jarfelt,et al. Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.
[173] R. Napoli,et al. Effects of growth hormone on exercise capacity and cardiopulmonary performance in patients with chronic heart failure. , 2007, The Journal of clinical endocrinology and metabolism.
[174] K. Hellmann. Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[175] S. Lipshultz,et al. Anthracycline associated cardiotoxicity in survivors of childhood cancer , 2007, Heart.
[176] R. Ross,et al. Abdominal obesity, liver fat, and muscle composition in survivors of childhood acute lymphoblastic leukemia. , 2007, The Journal of clinical endocrinology and metabolism.
[177] F. Shamsa,et al. High Blood Pressure Trends in Children and Adolescents in National Surveys, 1963 to 2002 , 2007, Circulation.
[178] Chao-Po Lin,et al. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. , 2007, Cancer research.
[179] J. Bryant,et al. Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: a systematic review. , 2007, European journal of cancer.
[180] E. Rosenkranz,et al. Ethical issues in children with cardiomyopathy: Making sense of ethical challenges in the clinical setting , 2007 .
[181] T. Merchant,et al. Noninvasive evaluation of late anthracycline cardiac toxicity in childhood cancer survivors. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[182] S. Rose,et al. Long-term endocrine sequelae of childhood cancer , 2007, Current opinion in pediatrics.
[183] L. Siu,et al. Molecularly targeted oncology therapeutics and prolongation of the QT interval. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[184] S. Lipsitz,et al. Dexrazoxane-associated risk for secondary malignancies in pediatric Hodgkin's disease: a claim without compelling evidence. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[185] T. Rowland,et al. A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthracyclines , 2007, Pediatric blood & cancer.
[186] L. Constine,et al. Late effects of therapy for Hodgkin’s lymphoma , 2007, Current hematologic malignancy reports.
[187] Monique W M Jaspers,et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. , 2007, JAMA.
[188] L. Robison,et al. Childhood cancer survivors, late effects, and a new model for understanding survivorship. , 2007, JAMA.
[189] D. Reinhardt,et al. Longitudinal evaluation of early and late anthracycline cardiotoxicity in children with AML , 2007, Pediatric blood & cancer.
[190] N. Carlsen,et al. Late cardiac effects of anthracycline containing therapy for childhood acute lymphoblastic leukemia , 2007, Pediatric blood & cancer.
[191] J. Ensor,et al. Long-term complications of platinum-based chemotherapy in testicular cancer survivors , 2007, Medical oncology.
[192] D. McDonald,et al. Mechanisms of adverse effects of anti-VEGF therapy for cancer , 2007, British Journal of Cancer.
[193] S. Blair,et al. Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. , 2007, JAMA.
[194] I. Papassotiriou,et al. Early Indicators of Dysmetabolic Syndrome in Young Survivors of Acute Lymphoblastic Leukemia in Childhood as a Target for Preventing Disease , 2007, Journal of pediatric hematology/oncology.
[195] H. Caron,et al. Prevention of anthracycline-induced cardiotoxicity in children: the evidence. , 2007, European journal of cancer.
[196] U. Walker,et al. Role of mtDNA lesions in anthracycline cardiotoxicity , 2007, Cardiovascular Toxicology.
[197] S. Lipshultz. Heart failure in childhood cancer survivors , 2007, Nature Clinical Practice Oncology.
[198] L. Gianni,et al. Anthracycline cardiotoxicity in breast cancer patients: synergism with trastuzumab and taxanes , 2007, Cardiovascular Toxicology.
[199] S. Lipshultz,et al. Anthracycline cardiotoxicity in long-term survivors of childhood cancer , 2007, Cardiovascular Toxicology.
[200] Delia Outomuro,et al. Adriamycin-induced myocardial toxicity: new solutions for an old problem? , 2007, International journal of cardiology.
[201] Marc S Jacobson,et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. , 2007, Circulation.
[202] J. Svensson,et al. A 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. , 2007, The Journal of clinical endocrinology and metabolism.
[203] Y. Arbel,et al. QT prolongation and Torsades de Pointes in patients previously treated with Anthracyclines , 2007, Anti-cancer drugs.
[204] S. Pomeroy,et al. Moyamoya following cranial irradiation for primary brain tumors in children , 2007, Neurology.
[205] A. Hart,et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. , 2007, Blood.
[206] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[207] K. Emmons,et al. Availability of smoking prevention and cessation services for childhood cancer survivors , 2007, Cancer Causes & Control.
[208] L. Constine,et al. Dexrazoxane-associated risk for acute myeloid leukemia/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin's disease. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[209] A. Horwich,et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. , 2007, Journal of the National Cancer Institute.
[210] L. Constine,et al. Long-term effects of treatments for childhood cancers , 2007, Current opinion in pediatrics.
[211] A. Alexandrov,et al. Guidelines for Screening of Extracranial Carotid Artery Disease: A Statement for Healthcare Professionals from the Multidisciplinary Practice Guidelines Committee of the American Society of Neuroimaging; Cosponsored by the Society of Vascular and Interventional Neurology , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[212] H. Caron,et al. Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study. , 2006, European journal of cancer.
[213] H. Caron,et al. Anthracycline-induced cardiotoxicity: comparison of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. , 2006, European journal of cancer.
[214] K. Steinbeck,et al. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. , 2006, The Journal of clinical endocrinology and metabolism.
[215] T. Merchant,et al. Effects of fractionated radiation on the brain vasculature in a murine model: blood-brain barrier permeability, astrocyte proliferation, and ultrastructural changes. , 2006, International journal of radiation oncology, biology, physics.
[216] S. Fosså,et al. Components of the metabolic syndrome in long-term survivors of testicular cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[217] Xin Huang,et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial , 2006, The Lancet.
[218] J. Vonk,et al. Long-term cardiac follow-up in survivors of a malignant bone tumour. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[219] K. Ness,et al. Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia , 2006, Cancer.
[220] W. Shi,et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. , 2006, The Journal of clinical endocrinology and metabolism.
[221] T. Wallimann,et al. New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics. , 2006, Journal of molecular and cellular cardiology.
[222] Robin L. Jones,et al. Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs , 2006, Expert review of anticancer therapy.
[223] S. Yusuf,et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.
[224] Kevin C Oeffinger,et al. Comprehensive long‐term follow‐up programs for pediatric cancer survivors , 2006, Cancer.
[225] Brian Walters,et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate , 2006, Nature Medicine.
[226] L. Fried,et al. The association of alcohol consumption and incident heart failure: the Cardiovascular Health Study. , 2006, Journal of the American College of Cardiology.
[227] L. Gianni,et al. Paclitaxel and Docetaxel Stimulation of Doxorubicinol Formation in the Human Heart: Implications for Cardiotoxicity of Doxorubicin-Taxane Chemotherapies , 2006, Journal of Pharmacology and Experimental Therapeutics.
[228] A. Ng,et al. Cardiac status predicts quality of life in Hodgkin's disease survivors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[229] S. Lipshultz. Exposure to anthracyclines during childhood causes cardiac injury. , 2006, Seminars in oncology.
[230] J. Kirklin,et al. Outcomes of Children Bridged to Heart Transplantation With Ventricular Assist Devices: A Multi-Institutional Study , 2006, Circulation.
[231] M. Vance,et al. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.
[232] K. Courneya,et al. An Examination of Physical Activity Behaviors in a Sample of Adolescent Cancer Survivors , 2006, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.
[233] P. Ridker,et al. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. , 2006, JAMA.
[234] K. Flaherty,et al. Mechanisms of hypertension associated with BAY 43-9006. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[235] K. Ness,et al. Physical performance limitations and participation restrictions among cancer survivors: a population-based study. , 2006, Annals of epidemiology.
[236] A. Støylen,et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. , 2006, Journal of the American College of Cardiology.
[237] T. Takken,et al. Physical function and fitness in long-term survivors of childhood leukaemia , 2006, Pediatric rehabilitation.
[238] S. Colan,et al. The relevance of information generated by in vitro experimental models to clinical doxorubicin cardiotoxicity , 2006, Leukemia & lymphoma.
[239] M. Pfreundschuh,et al. NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated With Doxorubicin-Induced Cardiotoxicity , 2005, Circulation.
[240] S. Grundy,et al. The metabolic syndrome. , 2008, Endocrine reviews.
[241] S. Lipshultz,et al. Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies , 2005, British journal of haematology.
[242] S. Sallan,et al. Wise up: Do not do it without protection! , 2005, Pediatric blood & cancer.
[243] J. Rowland,et al. Health behaviors of cancer survivors: examining opportunities for cancer control intervention. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[244] D. Moody,et al. Vascular Damage after Fractionated Whole-Brain Irradiation in Rats , 2005, Radiation Research.
[245] S. Hancock,et al. Diastolic dysfunction after mediastinal irradiation. , 2005, American heart journal.
[246] Q. Bashir,et al. Cardiotoxicity of cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[247] G. Dini,et al. Exercise capacity in apparently healthy survivors of cancer , 2005, Archives of Disease in Childhood.
[248] K. Emmons,et al. Peer-delivered smoking counseling for childhood cancer survivors increases rate of cessation: the partnership for health study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[249] Yan Liu,et al. Stroke as a late treatment effect of Hodgkin's Disease: a report from the Childhood Cancer Survivor Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[250] J. Twisk,et al. Effects of 10 years of growth hormone (GH) replacement therapy in adult GH‐deficient men , 2005, Clinical endocrinology.
[251] T. Wilsgaard,et al. Blood pressure and body mass index in long-term survivors of testicular cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[252] S. Rai,et al. Adolescent survivors: A secondary analysis of a clinical trial targeting behavior change , 2005, Pediatric blood & cancer.
[253] P. Raina,et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. , 2005, Evidence report/technology assessment.
[254] S. Russell,et al. Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy. , 2005, The Annals of thoracic surgery.
[255] S. Lipshultz,et al. Pathophysiology of anthracycline‐ and radiation‐associated cardiomyopathies: Implications for screening and prevention , 2005, Pediatric blood & cancer.
[256] P. Thompson,et al. Prevention of coronary artery disease in cancer patients , 2005, Pediatric blood & cancer.
[257] S. Lipsitz,et al. Cardiac Changes Associated With Growth Hormone Therapy Among Children Treated With Anthracyclines , 2005, Pediatrics.
[258] E. Coups,et al. A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls. , 2005, Preventive medicine.
[259] E. Clipp,et al. Survivors of childhood cancer and their guardians , 2005, Cancer.
[260] F. V. van Leeuwen,et al. Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. , 2005, Cancer treatment reviews.
[261] S. Lipshultz,et al. Exercise rehabilitation of pediatric patients with cardiovascular disease , 2005 .
[262] K. Aytemir,et al. Doxorubicin-induced second degree and complete atrioventricular block. , 2005, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[263] S. Lipsitz,et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[264] J. Towbin,et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. , 2005, Journal of the American College of Cardiology.
[265] N. Meydan,et al. Ultrasound Tissue Characterization by Integrated Backscatter for Analyzing Fluorouracil Induced Myocardial Damage , 2005, Echocardiography.
[266] L. F. Fajardo. The pathology of ionizing radiation as defined by morphologic patterns* , 2005, Acta oncologica.
[267] P. Morandi,et al. Cardiac toxicity of high-dose chemotherapy , 2005, Bone Marrow Transplantation.
[268] P. Libby,et al. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. , 2004, Circulation.
[269] D. Green,et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[270] R. D. de Haan,et al. Quality of life, self‐esteem and worries in young adult survivors of childhood cancer , 2004, Psycho-oncology.
[271] J. Björk,et al. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. , 2004, The Journal of clinical endocrinology and metabolism.
[272] G. Levitt,et al. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function , 2004, Heart.
[273] M. Thelen,et al. Anthrazyklin-induzierte Kardiotoxizität: MRT des Herzens bei Kindern und Jugendlichen mit malignen Erkrankungen , 2004 .
[274] C. Canter,et al. Pediatric heart transplantation for anthracycline cardiomyopathy: cancer recurrence is rare. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[275] K. Emmons,et al. Multiple risk behaviors among smokers in the childhood cancer survivors study cohort , 2004, Psycho-oncology.
[276] L. Robison,et al. Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[277] S. Lipsitz,et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[278] S. Lipsitz,et al. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. , 2004, The New England journal of medicine.
[279] J. Svensson,et al. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy. , 2004, The Journal of clinical endocrinology and metabolism.
[280] Sonia Caprio,et al. Obesity and the metabolic syndrome in children and adolescents. , 2004, The New England journal of medicine.
[281] L. Gianni,et al. Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity , 2004, Pharmacological Reviews.
[282] P. Merlet,et al. Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy , 2004, British Journal of Cancer.
[283] P. Chanson,et al. Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. , 2004, The Journal of clinical endocrinology and metabolism.
[284] K. Ohta,et al. QT dispersion correlates with systolic rather than diastolic parameters in patients receiving anthracycline treatment. , 2004, Internal medicine.
[285] B. Barlogie,et al. Bradycardia during therapy for multiple myeloma with thalidomide. , 2004, The American journal of cardiology.
[286] S. Lipsitz,et al. A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses. , 2004, Pediatrics.
[287] Weiling Zhao,et al. Chronic oxidative stress and radiation‐induced late normal tissue injury: a review , 2004, International journal of radiation biology.
[288] R. Packer,et al. Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. , 2004, Neuro-oncology.
[289] A. Santoro,et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[290] C. McMahon,et al. Impact of cardiac growth on Doppler tissue imaging velocities: a study in healthy children. , 2004, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[291] D. Lai,et al. Overweight, ethnicity, and the prevalence of hypertension in school-aged children. , 2004, Pediatrics.
[292] S. Colan,et al. Cardiovascular trials in long-term survivors of childhood cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[293] J. Silber,et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[294] C. Pepine,et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy. , 2003, JAMA.
[295] S. Dobrić,et al. Amifostine protection against doxorubicin cardiotoxicity in rats , 2004, Anti-cancer drugs.
[296] G. Levitt,et al. Does anthracycline administration by infusion in children affect late cardiotoxicity? , 2004, British journal of haematology.
[297] E. Perez,et al. Clinical cardiac tolerability of trastuzumab. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[298] G. Berry,et al. Cardiac Safety of Pegylated Liposomal Doxorubicin (Doxil®/Caelyx®) Demonstrated by Endomyocardial Biopsy in Patients with Advanced Malignancies , 2004, Cancer investigation.
[299] A. Aljada,et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. , 2003, Diabetes.
[300] Jörg Haberstroh,et al. Time-Dependent and Tissue-Specific Accumulation of mtDNA and Respiratory Chain Defects in Chronic Doxorubicin Cardiomyopathy , 2003, Circulation.
[301] Michael D. Schneider,et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[302] S. Goldhaber,et al. Trace element risk assessment: essentiality vs. toxicity. , 2003, Regulatory toxicology and pharmacology : RTP.
[303] Paul Chen,et al. Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation. , 2003, Cancer research.
[304] H. Bartelink,et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[305] E. Ford. C-Reactive Protein Concentration and Cardiovascular Disease Risk Factors in Children: Findings From the National Health and Nutrition Examination Survey 1999–2000 , 2003, Circulation.
[306] H. Caron,et al. Treatment for asymptomatic anthracycline-induced cardiac dysfunction in childhood cancer survivors: the need for evidence. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[307] S. Hancock,et al. Asymptomatic cardiac disease following mediastinal irradiation. , 2003, Journal of the American College of Cardiology.
[308] T. Safra. Cardiac safety of liposomal anthracyclines. , 2003, The oncologist.
[309] Takashi Okamoto,et al. Sino-atrial block during anesthesia in a patient with breast cancer being treated with the anticancer drug epirubicin. , 2003, Anesthesia and analgesia.
[310] L. Constine,et al. Radiation-associated cardiovascular disease: manifestations and management. , 2003, Seminars in radiation oncology.
[311] Daniel Levy,et al. The Epidemiology of Asymptomatic Left Ventricular Systolic Dysfunction: Implications for Screening , 2003, Annals of Internal Medicine.
[312] N. Cheung,et al. Late cardiotoxicity after bolus versus infusion anthracycline therapy for childhood cancers. , 2003, Medical and pediatric oncology.
[313] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[314] G. Levitt,et al. Late anthracycline cardiotoxicity after childhood cancer , 2003, Cancer.
[315] E. Laurila,et al. Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. , 2003, The Journal of clinical endocrinology and metabolism.
[316] J. Gattuso,et al. Intervention to reduce intentions to use tobacco among pediatric cancer survivors. , 2003, Journal of Clinical Oncology.
[317] T. Fears,et al. Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[318] C. Yajnik,et al. -to: Hales CN, Barker DJP (1992) Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 35:595–601 , 2003, Diabetologia.
[319] L. Robison,et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors , 2003, Cancer.
[320] Gary L Myers,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[321] K. Kodama,et al. Radiation dose-dependent increases in inflammatory response markers in A-bomb survivors , 2003, International journal of radiation biology.
[322] S. Lipsitz,et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[323] J. Mackey,et al. The lack of long-term effect of Cisplatin based combination chemotherapy on serum cholesterol for treatment of testicular cancer. , 2002, The Journal of urology.
[324] J. Quiles,et al. Antioxidant nutrients and adriamycin toxicity. , 2002, Toxicology.
[325] Richard V. Williams,et al. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[326] W. Kamps,et al. Cardiac status in bone tumor survivors up to nearly 19 years after treatment with doxorubicin: a longitudinal study. , 2002, Medical and pediatric oncology.
[327] A. Smit,et al. The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. , 2002, Cancer treatment reviews.
[328] M. Preece,et al. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study , 2002, The Lancet.
[329] L. Robison,et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. , 2002, The Journal of clinical endocrinology and metabolism.
[330] P. Voûte,et al. Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[331] D. Gaudet,et al. Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia , 2002, Circulation.
[332] J. Svensson,et al. Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. , 2002, The Journal of clinical endocrinology and metabolism.
[333] K. Emmons,et al. Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[334] S. Lipsitz,et al. Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[335] J. Warner,et al. Body composition of long-term survivors of acute lymphoblastic leukaemia. , 2002, Medical and pediatric oncology.
[336] C. Ardies. Exercise, Cachexia, and Cancer Therapy: A Molecular Rationale , 2002, Nutrition and cancer.
[337] C. Hudis,et al. Cardiac dysfunction in the trastuzumab clinical trials experience. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[338] R. Vasan,et al. Alcohol Consumption and Risk for Congestive Heart Failure in the Framingham Heart Study , 2002, Annals of Internal Medicine.
[339] M. Link,et al. Dose escalation and pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in children with solid tumors: a pediatric oncology group study. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[340] H. Thaler,et al. PRESENCE OF PROLONGED DISPERSION OF QT INTERVALS IN LATE SURVIVORS OF CHILDHOOD ANTHRACYCLINE THERAPY , 2002, Pediatric hematology and oncology.
[341] S. Lipshultz,et al. Cardiomyopathy caused by antineoplastic therapies , 2001, Current treatment options in cardiovascular medicine.
[342] D. Jacobs,et al. Insulin resistance syndrome in childhood: associations of the euglycemic insulin clamp and fasting insulin with fatness and other risk factors. , 2001, The Journal of pediatrics.
[343] B. Guy-grand,et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study , 2001, The Lancet.
[344] V. Ferrans,et al. The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity , 2001, Cancer Chemotherapy and Pharmacology.
[345] M. Galderisi,et al. Left ventricular systolic and diastolic function after anthracycline chemotherapy in childhood , 2001, Clinical cardiology.
[346] M. Alpsten,et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices. , 2001, The Journal of clinical endocrinology and metabolism.
[347] M. Denke,et al. Cardiovascular Risk Factors in Young Adult Survivors of Childhood Acute Lymphoblastic Leukemia , 2001, Journal of pediatric hematology/oncology.
[348] J. Reilly,et al. Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. , 2001, The Journal of clinical endocrinology and metabolism.
[349] E Glattre,et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[350] A. D. Cunningham,et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population , 2001, Heart.
[351] J. Schulz-Menger,et al. Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study. , 2001, American heart journal.
[352] F. Cetta,et al. Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. , 2001, The American journal of cardiology.
[353] D. Jacobs,et al. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. , 2001, The Journal of pediatrics.
[354] D. Galuska,et al. C-reactive protein and body mass index in children: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. , 2001, The Journal of pediatrics.
[355] N. Breslow,et al. Congestive heart failure after treatment for Wilms' tumor: a report from the National Wilms' Tumor Study group. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[356] C. Canter,et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. , 2001, The Journal of pediatrics.
[357] G. Batist,et al. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[358] M. Goran. Metabolic precursors and effects of obesity in children: a decade of progress, 1990-1999. , 2001, The American journal of clinical nutrition.
[359] E. Nakashima,et al. Persistent subclinical inflammation among A-bomb survivors , 2001, International journal of radiation biology.
[360] N. Labropoulos,et al. A Prospective Study of the Effects of Irradiation on the Carotid Artery , 2000, The Laryngoscope.
[361] M. Sontag,et al. Late Effects of Ionizing Radiation on the Microvascular Networks in Normal Tissue , 2000, Radiation research.
[362] J. Jørgensen,et al. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. , 2000, The Journal of clinical endocrinology and metabolism.
[363] S. Müller-Weihrich,et al. Myocardial high-energy phosphate metabolism is altered after treatment with anthracycline in childhood , 2000, Cardiology in the Young.
[364] J. Newell,et al. Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia , 2000, International Journal of Obesity.
[365] J. Schlessinger,et al. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[366] T. Spinks,et al. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults. , 2000, The Journal of clinical endocrinology and metabolism.
[367] J. Thijssen,et al. Tissue Doppler imaging in detection of myocardial dysfunction in survivors of childhood cancer treated with anthracyclines. , 2000, Ultrasound in medicine & biology.
[368] L. Caprino,et al. Cisplatin triggers platelet activation. , 2000, Thrombosis research.
[369] L. Robison,et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. , 2000, Medical and pediatric oncology.
[370] W. Kamps,et al. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group. , 2000, Medical and pediatric oncology.
[371] M. Ranke,et al. Energy Expenditure, Energy Intake and Prevalence of Obesity after Therapy for Acute Lymphoblastic Leukemia during Childhood , 2000, Hormone Research in Paediatrics.
[372] Chulhyun Kim,et al. Association between birth weight and insulin sensitivity in healthy young men in Korea: role of visceral adiposity. , 2000, Diabetes research and clinical practice.
[373] G R Sutherland,et al. Assessment of regional longitudinal myocardial strain rate derived from doppler myocardial imaging indexes in normal and infarcted myocardium. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[374] N. Skakkebaek,et al. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. , 2000, The Journal of clinical endocrinology and metabolism.
[375] P. Armstrong,et al. Adverse effects of corticosteroids on the cardiovascular system. , 2000, The Canadian journal of cardiology.
[376] E. Shpall,et al. Cardiac toxicity following high-dose cyclophosphamide, cisplatin, and BCNU (STAMP-I) for breast cancer. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[377] P. Czernichow,et al. Insulin resistance early in adulthood in subjects born with intrauterine growth retardation. , 2000, The Journal of clinical endocrinology and metabolism.
[378] D. Strachan,et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. , 2000, Atherosclerosis.
[379] Clive Osmond,et al. Effects of Infant Birthweight and Maternal Body Mass Index in Pregnancy on Components of the Insulin Resistance Syndrome in China , 2000, Annals of Internal Medicine.
[380] W. Wallace,et al. OBESITY IN LEUKEMIA SURVIVORS: The Familial Contribution , 2000, Pediatric hematology and oncology.
[381] C. Mølgaard,et al. Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. , 1999, The Journal of clinical endocrinology and metabolism.
[382] S. Nussey,et al. Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index , 1999, Archives of disease in childhood.
[383] P Colonna,et al. Effects of acute myocardial ischemia on intramyocardial contraction heterogeneity: A study performed with ultrasound integrated backscatter during transesophageal atrial pacing. , 1999, Circulation.
[384] D. Green,et al. Cancer and cardiac mortality among 15-year survivors of cancer diagnosed during childhood or adolescence. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[385] W. Hobbie,et al. Testing the effects of a decision-making and risk-reduction program for cancer-surviving adolescents. , 1999, Oncology nursing forum.
[386] T. Yokoyama,et al. Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription. , 1999, Circulation research.
[387] J. Debus,et al. Delayed vascular injury after single high-dose irradiation in the rat brain: histologic immunohistochemical, and angiographic studies. , 1999, Radiology.
[388] V. Ferrans,et al. Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[389] S. Gidding,et al. Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[390] S. Colan,et al. Doxorubicin-induced cardiomyopathy. , 1999, The New England journal of medicine.
[391] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[392] B. Bülow,et al. A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF‐I without significant deterioration in glucose tolerance , 1999, Clinical endocrinology.
[393] Y. C. Chen,et al. Acute and chronic arsenic poisoning associated with treatment of acute promyelocytic leukaemia , 1998, British journal of haematology.
[394] P. Singal,et al. Doxorubicin-induced cardiomyopathy. , 1998, The New England journal of medicine.
[395] M. Packer,et al. Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. , 1998, Circulation.
[396] W. Dietz,et al. Obesity Evaluation and Treatment: Expert Committee Recommendations , 1998 .
[397] T. Spinks,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Effects of 10 Years of Recombinant Human Growth Hormone (GH) in Adult GH-Deficient Patients , 2022 .
[398] S. Lipshultz,et al. Epidemiology of anthracycline cardiotoxicity in children and adults. , 1998, Seminars in oncology.
[399] R. Tracy,et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. , 1998, The New England journal of medicine.
[400] P. Trumbo,et al. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. , 1998, Journal of the American Dietetic Association.
[401] D. Johnston,et al. Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH‐deficient adults , 1998, Clinical endocrinology.
[402] J. Christiansen,et al. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. , 1998, Medical and pediatric oncology.
[403] C. Rantzau,et al. Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy. , 1998, The Journal of clinical endocrinology and metabolism.
[404] G. Rosner,et al. Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation. , 1998, Radiation research.
[405] J. Gorcsan,et al. Quantification of the myocardial response to low-dose dobutamine using tissue Doppler echocardiographic measures of velocity and velocity gradient. , 1998, The American journal of cardiology.
[406] C. Hennekens. Risk factors for coronary heart disease in women. , 1998, Cardiology clinics.
[407] S. Lipsitz,et al. Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[408] T. Robinson,et al. Use of the body mass index (BMI) as a measure of overweight in children and adolescents. , 1998, The Journal of pediatrics.
[409] M. Goran,et al. Assessment of research-based body composition techniques in healthy elderly men and women using the 4-compartment model as a criterion method , 1998, International Journal of Obesity.
[410] D B Allison,et al. Body mass index as a measure of adiposity among children and adolescents: a validation study. , 1998, The Journal of pediatrics.
[411] M. Bristow. Mechanism of action of beta-blocking agents in heart failure. , 1997, The American journal of cardiology.
[412] I. Goldenberg,et al. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. , 1997, The American journal of the medical sciences.
[413] J. Krischer,et al. Risk factors for early anthracycline clinical cardiotoxicity in children: the pediatric oncology group experience , 1997 .
[414] S. Lipsitz,et al. Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. , 1997, Circulation.
[415] L. Ho,et al. Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience. , 1997 .
[416] N. Skakkebaek,et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. , 1997, The Journal of clinical endocrinology and metabolism.
[417] X. Thomas,et al. Mitoxantrone in the treatment of acute myelogenous leukemia: a review. , 1997, Hematology and cell therapy.
[418] L. Burke,et al. Symptomatic Cardiotoxicity Associated with 5‐Fluorouracil , 1997, Pharmacotherapy.
[419] T. Cole,et al. Review: Measurement and long-term health risks of child and adolescent fatness , 1997, International Journal of Obesity.
[420] R. Martino,et al. A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolism. , 1997, Cellular and molecular biology.
[421] H. Lamb,et al. Oral Idarubicin , 1997, Drugs & aging.
[422] P. Heidenreich,et al. Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. , 1997, Journal of the American College of Cardiology.
[423] Ibrahim Özdoğru,et al. Correction: Pregnancy-Related Thromboembolism , 1997, Annals of Internal Medicine.
[424] M. Kimura,et al. Influence of selenium deficiency on the acute cardiotoxicity of adriamycin in rats , 1997, Biological Trace Element Research.
[425] J. Krischer,et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[426] S. Sallan,et al. Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. , 1997, Blood.
[427] B. Perret,et al. Impaired secretion of heart lipoprotein lipase in cyclophosphamide-treated rabbit. , 1997, Biochimica et biophysica acta.
[428] C. Bokemeyer,et al. Evaluation of long-term toxicity after chemotherapy for testicular cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[429] W. Tamborlane,et al. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children , 1996, Diabetologia.
[430] J. Manson,et al. Obesity and cardiovascular disease. , 1996, Current opinion in cardiology.
[431] L. Vecchia. Physiologic Dual Chamber Pacing in Radiation-lnduced Atrioventricular Block , 1996 .
[432] M. Knip,et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. , 1996, The Journal of clinical endocrinology and metabolism.
[433] W. Edwards,et al. Pathology of radiation-induced heart disease: A surgical and autopsy study of 27 cases , 1996 .
[434] S. Tonstad,et al. Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia. , 1996, The Journal of pediatrics.
[435] Hancock,et al. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. , 1996, Seminars in radiation oncology.
[436] S. Ferrari,et al. The role of corrected QT interval in the cardiologic follow-up of young patients treated with Adriamycin. , 1996, Journal of chemotherapy.
[437] J. Kongerud,et al. Increased risk of heart valve regurgitation after mediastinal radiation for Hodgkin's disease: an echocardiographic study. , 1996, Heart.
[438] A. R. Marchese,et al. Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis. , 1996, Cardiovascular surgery.
[439] L. Sjöström,et al. Comparison of methods to estimate body fat in growth hormone deficient adults , 1996, Clinical endocrinology.
[440] S. Arslanian,et al. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present? , 1996, The Journal of clinical endocrinology and metabolism.
[441] A S Leon,et al. Physical activity, nutrition, and chronic disease. , 1996, Medicine and science in sports and exercise.
[442] R. Considine,et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.
[443] S. Lipshultz. Dexrazoxane for protection against cardiotoxic effects of anthracyclines in children. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[444] S. Srinivasan,et al. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. , 1996, Metabolism: clinical and experimental.
[445] L. Packer,et al. Vitamin E: beyond antioxidant function. , 1995, The American journal of clinical nutrition.
[446] E. Schuetz,et al. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. , 1995, The Journal of pharmacology and experimental therapeutics.
[447] E. Ravussin,et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.
[448] M. Deitel,et al. Increased obese mRNA expression in omental fat cells from massively obese humans , 1995, Nature Medicine.
[449] A. Meadows. Curing cancer in children: minimizing price, maximizing value. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[450] M. Pelleymounter,et al. Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.
[451] Steven L. Cohen,et al. Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.
[452] F. Lampert,et al. Severe cardiotoxicity of high-dose 5-fluorouracil in combination with folinic acid, cisplatin and methotrexate in a 14-year-old boy with nasopharyngeal carcinoma (Schmincke tumor). , 1995, Oncology.
[453] A. Ogilvy-Stuart,et al. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. , 1995, The Journal of pediatrics.
[454] E J Orav,et al. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. , 1995, The New England journal of medicine.
[455] P. Steinherz,et al. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. , 1995, Medical and pediatric oncology.
[456] L. Kalish,et al. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. , 1995, The cancer journal from Scientific American.
[457] M. Siimes,et al. Cardiopulmonary evaluation of exercise tolerance after chest irradiation and anticancer chemotherapy in children and adolescents. , 1995, Pediatrics.
[458] V. Katch,et al. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. , 1995, The Journal of pediatrics.
[459] M. Korth,et al. Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium. , 1995, Circulation research.
[460] J. R. Stewart,et al. Radiation injury to the heart. , 1995, International journal of radiation oncology, biology, physics.
[461] C. Sklar,et al. Chronic neuroendocrinological sequelae of radiation therapy. , 1995, International journal of radiation oncology, biology, physics.
[462] Cheng Jiang,et al. Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. , 1995, Carcinogenesis.
[463] R. Pardini,et al. Enhancement of the antineoplastic effect of mitomycin C by dietary fat. , 1994, Cancer research.
[464] R. Dorr,et al. Effect of sulfhydryl compounds and glutathione depletion on rat heart myocyte toxicity induced by 4-hydroperoxycyclophosphamide and acrolein in vitro. , 1994, Chemico-biological interactions.
[465] D. O'Neal,et al. The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis. , 1994, The Journal of clinical endocrinology and metabolism.
[466] L. Tesoriere,et al. Vitamin A preserves the cytotoxic activity of adriamycin while counteracting its peroxidative effects in human leukemic cells in vitro. , 1994, Biochemistry and molecular biology international.
[467] J. Reilly,et al. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. , 1994, Archives of disease in childhood.
[468] K. Schärer,et al. Usefulness of Bioelectric Impedance and Skinfold Measurements in Predicting Fat-Free Mass Derived from Total Body Potassium in Children , 1994, Pediatric Research.
[469] S. Colan,et al. Monitoring for anthracycline cardiotoxicity. , 1994, Pediatrics.
[470] M. Verheij,et al. Ionizing radiation enhances platelet adhesion to the extracellular matrix of human endothelial cells by an increase in the release of von Willebrand factor. , 1994, Radiation research.
[471] J. Manson,et al. Body weight and mortality. A 27-year follow-up of middle-aged men. , 1993, JAMA.
[472] D. Wysowski,et al. Risk of leukemia after treatment with pituitary growth hormone. , 1993, JAMA.
[473] B. Bengtsson,et al. Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. , 1993, Metabolism: clinical and experimental.
[474] S L Hancock,et al. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. , 1993, JAMA.
[475] E. Ravussin,et al. Estimating body composition of young children by using bioelectrical resistance. , 1993, Journal of applied physiology.
[476] M. Horimoto,et al. Pulmonary infundibular stenosis, coronary artery disease, and aortic regurgitation caused by mediastinal radiation. , 1993, American heart journal.
[477] H. Toshima,et al. A deletion of mitochondrial DNA in murine doxorubicin-induced cardiotoxicity. , 1993, Biochemical and biophysical research communications.
[478] E. Thiel,et al. Evaluation of late cardiotoxicity with pulsed Doppler echocardiography in patients treated for Hodgkin's disease , 1993, British journal of haematology.
[479] M. Rousseau,et al. Effects of long-term enalapril therapy on left ventricular diastolic properties in patients with depressed ejection fraction. SOLVD Investigators. , 1993, Circulation.
[480] S. Sallan,et al. Cardiovascular abnormalities in long-term survivors of childhood malignancy. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[481] J. Silber,et al. Cardiac dysfunction following spinal irradiation during childhood. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[482] R. Demicheli,et al. Drugs ten years later: epirubicin. , 1993, Annals of oncology : official journal of the European Society for Medical Oncology.
[483] F. Gaita,et al. Associated cardiac lesions in patients with radiation-induced complete heart block. , 1993, International journal of cardiology.
[484] R. Brown,et al. Survival of cancer patients on therapy with coenzyme Q10. , 1993, Biochemical and biophysical research communications.
[485] A. Neims,et al. 4‐Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells , 1993, Journal of cellular biochemistry.
[486] L. Steinherz,et al. Sick sinus syndrome in a teenager treated with idarubicin. , 1993, Journal of cardiothoracic and vascular anesthesia.
[487] J. K. Lloyd,et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.
[488] D. Levy,et al. Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). , 1992, The American journal of cardiology.
[489] H. Caron,et al. Cancer in Children: Clinical Management , 1992 .
[490] C. Hales,et al. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.
[491] J. Kupersmith,et al. Prolongation of isovolumetric relaxation time as assessed by Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. , 1992, Journal of the American College of Cardiology.
[492] J. Silber,et al. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. , 1992, The American journal of cardiology.
[493] A. Bartolucci,et al. A phase III trial comparing idarubicin and daunorubicin in combination with cytarabine in acute myelogenous leukemia: a Southeastern Cancer Study Group Study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[494] R. Schwartz,et al. Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. , 1992, Pediatrics.
[495] J. G. Miller,et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. , 1992, Journal of the American College of Cardiology.
[496] J. Arnaud,et al. Effects of adriamycin on chronic cardiotoxicity in selenium-deficient rats , 1992, Basic Research in Cardiology.
[497] Ncep Expert Panel on Blood Cholesterol Levels in Childr Adolescents. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. , 1992, Pediatrics.
[498] M. Shamoto,et al. Ascorbic acid and adriamycin toxicity. , 1991, The American journal of clinical nutrition.
[499] V. Martí,et al. Coronary arterial spasm and cardiac arrest following mediastinal radiation therapy for Hodgkin's disease. , 1991, Chest.
[500] P. Steinherz,et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. , 1991, JAMA.
[501] E K Rowinsky,et al. Cardiac disturbances during the administration of taxol. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[502] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[503] E. Cook,et al. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[504] S. Colan,et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. , 1991, The New England journal of medicine.
[505] J. Doroshow. Doxorubicin-induced cardiac toxicity. , 1991, The New England journal of medicine.
[506] J. Alexander,et al. Radiation-associated valvular disease. , 1991, Chest.
[507] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[508] B. Griffith,et al. Heart transplantation in patients with malignant disease. , 1990, The Journal of heart transplantation.
[509] T. Landberg,et al. Original article: Late cardiac effects after mantle radiotherapy in patients with Hodgkin's disease , 1990 .
[510] R. Brasseur,et al. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. , 1990, Biophysical chemistry.
[511] M. Yacoub,et al. CARDIAC TRANSPLANTATION FOR DOXORUBICIN‐INDUCED CARDIOMYOPATHY IN ACUTE MYELOID LEUKAEMIA , 1990, British journal of haematology.
[512] P. Hekali,et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. , 1990, Bone marrow transplantation.
[513] D. Ettinger,et al. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. , 1989 .
[514] S. Sallan,et al. Hypertension in long-term survivors of childhood renal cancers. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[515] R. Willson,et al. Vitamin A and glutathione-mediated free radical damage: competing reactions with polyunsaturated fatty acids and vitamin C. , 1989, Biochemical and biophysical research communications.
[516] Y. S. Lee,et al. Doxorubicin-induced calcium release from cardiac sarcoplasmic reticulum vesicles. , 1989, Journal of molecular and cellular cardiology.
[517] F. Bonetti,et al. Heart transplantation in a child with doxorubicin-induced cardiomyopathy. , 1988, The New England journal of medicine.
[518] J. Verweij,et al. A prospective study on the dose dependency of cardiotoxicity induced by mitomycin C , 1988, Medical oncology and tumor pharmacotherapy.
[519] M. Ogura,et al. The occurrence of acute lymphoblastic leukemia shortly after the cessation of human growth hormone therapy. , 1988, Japanese journal of clinical oncology.
[520] D. Pennington,et al. Bridging to cardiac transplantation with pulsatile ventricular assist devices. , 1988, The Annals of thoracic surgery.
[521] J. Lintermans,et al. Orthotopic heart transplantation eleven years after left pneumonectomy. , 1988, The Journal of heart transplantation.
[522] J. Ward,et al. Uptake of WR-2721 derivatives by cells in culture: identification of the transported form of the drug. , 1988, Cancer research.
[523] U. Sasaki,et al. Occurrence of acute lymphoblastic leukemia in a boy treated with growth hormone for growth retardation after irradiation to the brain tumor. , 1988, Japanese journal of clinical oncology.
[524] W. C. Sheldon,et al. Clinical and angiographic features of coronary artery disease after chest irradiation. , 1987, The American journal of cardiology.
[525] K. Dohi,et al. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. , 1987, Surgery.
[526] M. Fiorotto,et al. Total body electrical conductivity measurements: effects of body composition and geometry. , 1987, The American journal of physiology.
[527] M. Goldberg,et al. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. , 1986, Blood.
[528] J. Hainsworth,et al. Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. , 1986, Annals of internal medicine.
[529] S. Marsoni,et al. Amsacrine-associated cardiotoxicity: an analysis of 82 cases. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[530] Gerald S. Berenson,et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis: the Bogalusa heart study , 1986 .
[531] K. Ingold,et al. Antioxidant and co-antioxidant activity of vitamin C. The effect of vitamin C, either alone or in the presence of vitamin E or a water-soluble vitamin E analogue, upon the peroxidation of aqueous multilamellar phospholipid liposomes. , 1985, Biochimica et biophysica acta.
[532] B. Issell,et al. Amsacrine (AMSA)--a clinical review. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[533] L. F. Fajardo,et al. Radiation-induced heart disease: an update. , 1984 .
[534] L. Liu,et al. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. , 1984, Science.
[535] S. Colan,et al. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. , 1984, Journal of the American College of Cardiology.
[536] J. Glick,et al. Phase I trials of WR-2721 and cis-platinum. , 1984, International journal of radiation oncology, biology, physics.
[537] G. Gaedicke,et al. Therapy of acute lymphocytic leukemia in childhood with intermediate dose methotrexate and CNS irradiation , 1983, Blut.
[538] Manning Feinleib,et al. Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.
[539] M. Hafermann,et al. Coronary artery disease following mediastinal radiation therapy. , 1983, The Journal of thoracic and cardiovascular surgery.
[540] F. Haschke,et al. Body composition of reference children from birth to age 10 years. , 1982, The American journal of clinical nutrition.
[541] S. Wallace,et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.
[542] E. W. Bradley,et al. Coronary arteriosclerosis and atherosclerosis in fast neutron or photon irradiated dogs. , 1981, International journal of radiation oncology, biology, physics.
[543] R. D. Couch,et al. Sudden cardiac death following adriamycin therapy , 1981, Cancer.
[544] J. Gottdiener,et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. , 1981, Archives of internal medicine.
[545] S. I. Cohen,et al. Radiotherapy as a cause of complete atrioventricular block in Hodgkin's disease. An electrophysiological-pathological correlation. , 1981, Archives of internal medicine.
[546] W. Roberts,et al. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. , 1981, The American journal of medicine.
[547] H. Pinedo,et al. Failure of the antioxidant vitamin E to protect against adriamycin-induced cardiotoxicity in the rabbit. , 1980, Cancer research.
[548] Y. M. Wang,et al. Effect of vitamin E against adriamycin-induced toxicity in rabbits. , 1980, Cancer research.
[549] V. Ferrans,et al. Cardiac disease induced by chronic adriamycin administration in dogs and an evaluation of vitamin E and selenium as cardioprotectants. , 1980, The American journal of pathology.
[550] H. von Melchner,et al. Adriamycin cardiotoxicity: a survey of 1273 patients. , 1979, Cancer treatment reports.
[551] A. B. Combs,et al. Rescue by coenzyme Q10 from electrocardiographic abnormalities caused by the toxicity of adriamycin in the rat. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[552] K. Folkers,et al. Adriamycin cardiotoxicity: early detection by systolic time interval and possible prevention by coenzyme Q10. , 1978, Cancer treatment reports.
[553] Van Vleet Jf,et al. Effect of selenium-vitamin E on adriamycin-induced cardiomyopathy in rabbits. , 1978 .
[554] J. Mason,et al. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. , 1978, Annals of internal medicine.
[555] I. Ifrim,et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumor response. , 1977, Science.
[556] L. F. Fajardo. Radiation-induced coronary artery disease. , 1977, Chest.
[557] R. Carmel,et al. Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications , 1976, Cancer.
[558] T. Kishi,et al. Letter: Prevention by coenzyme Q10 (NSC-140865) of the inhibition by adriamycin (NSC-123127) of coenzyme Q10 enzymes. , 1976, Cancer treatment reports.
[559] S. Sternberg,et al. The cardiotoxicity of adriamycin and daunomycin in children , 1976, Cancer.
[560] R. Byhardt,et al. Dose and treatment factors in radiation related pericardial effusion associated with the mantle technique for Hodgkin's disease , 1975, Cancer.
[561] C. G. Blomqvist,et al. Deficiency of coenzyme Q10 in hypertensive rats and reduction of deficiency by treatment with coenzyme Q10. , 1974, Biochemical and biophysical research communications.
[562] M. At,et al. Late effects of cancer treatment: methods and techniques for detection. , 1974 .
[563] A. Tappel,et al. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. , 1966, The Journal of biological chemistry.
[564] H. Lofland,et al. Ionizing radiation, atherosclerosis, and lipid metabolism in pigeons. , 1965, Radiation research.
[565] G. Amromin,et al. THE SYNERGISM OF X-IRRADIATION AND CHOLESTEROL-FAT FEEDING ON THE DEVELOPMENT OF CORONARY ARTERY LESIONS. , 1964, Journal of atherosclerosis research.
[566] S. Lindsay,et al. Aortic Arteriosclerosis in the Dog After Localized Aortic X‐lrradiation , 1962, Circulation research.
[567] J. Stockman. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort , 2011 .
[568] G. Recondo,et al. Antineoplastic chemotherapy induced QTc prolongation. , 2010, Current drug safety.
[569] Tongyu Lin,et al. Long-term results of pirarubicin versus doxorubicin in combination chemotherapy for aggressive non-Hodgkin’s lymphoma: single center, 15-year experience , 2010, International journal of hematology.
[570] K. Emmons,et al. Long-term smoking cessation outcomes among childhood cancer survivors in the Partnership for Health Study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[571] R Wakeford,et al. A Systematic Review of Epidemiological Associations between Low and Moderate Doses of Ionizing Radiation and Late Cardiovascular Effects, and Their Possible Mechanisms , 2008, Radiation research.
[572] K. Trott,et al. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data? , 2007, International journal of radiation oncology, biology, physics.
[573] A. Favier,et al. Lipid peroxidation products, and vitamin and trace element status in patients with cancer before and after chemotherapy, including adriamycin , 2007, Biological Trace Element Research.
[574] Margarita Pérez,et al. Effects of an intrahospital exercise program intervention for children with leukemia. , 2007, Medicine and science in sports and exercise.
[575] S. Lipshultz,et al. Cardiotoxicity of Cancer Chemotherapy , 2005, Paediatric drugs.
[576] W. Stöhr,et al. Comparison of epirubicin and doxorubicin cardiotoxicity in children and adolescents treated within the German Cooperative Soft Tissue Sarcoma Study (CWS) , 2005, Journal of Cancer Research and Clinical Oncology.
[577] S. Treves,et al. Cardiac toxicity of mediastinal radiotherapy : Which are the critical structures? , 2005 .
[578] J. Toumbourou,et al. Health-risk behaviours among adolescent survivors of childhood cancer. , 2005, Pediatric blood & cancer.
[579] G. Prindull,et al. The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia , 2004, European Journal of Pediatrics.
[580] C. Osmond,et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth , 2004, Diabetologia.
[581] A. La Cava,et al. Unraveling the multiple roles of leptin in inflammation and autoimmunity , 2004, Journal of Molecular Medicine.
[582] M. Vassilomanolakis,et al. Ifosfamide cardiotoxicity in humans , 2004, Cancer Chemotherapy and Pharmacology.
[583] H. Caron,et al. Cumulative incidence and risk factors of mitoxantrone-induced cardiotoxicity in children: a systematic review. , 2004, European journal of cancer.
[584] Steven E Lipshultz,et al. Radiation-associated cardiovascular disease. , 2003, Critical reviews in oncology/hematology.
[585] M. Lorenzato,et al. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment. , 2003, Anticancer research.
[586] B. Fervers,et al. Evidence-based paediatric oncology , 2002 .
[587] Lyndsay Harris,et al. Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma , 2002, Cancer.
[588] R. Murray,et al. GH-deficient survivors of childhood cancer: GH replacement during adult life. , 2002, The Journal of clinical endocrinology and metabolism.
[589] Mario J. Garcia,et al. Doppler-Derived Myocardial Systolic Strain Rate Is a Strong Index of Left Ventricular Contractility , 2002, Circulation.
[590] S. Chen,et al. Clinical spectrum of restrictive cardiomyopathy in children. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[591] N. Mayr,et al. Late effects in children treated with radiation therapy for Wilms' tumor. , 2000, International journal of radiation oncology, biology, physics.
[592] V. Ferrans,et al. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats , 2000, Cancer Chemotherapy and Pharmacology.
[593] L. Ries,et al. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995. , 1999 .
[594] C. Takahashi,et al. Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures. , 1999, Teratogenesis, carcinogenesis, and mutagenesis.
[595] P. Kaufmann,et al. Cardiac risk after mediastinal irradiation for Hodgkin's disease. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[596] S. Lipshultz,et al. Anthracycline-induced cardiotoxicity in children and young adults. , 1998, Critical reviews in oncology/hematology.
[597] S. Colan,et al. Late cardiotoxicity following anthracycline therapy for childhood cancer , 1998 .
[598] G. Reaven. Insulin Resistance and Human Disease: A Short History , 1998, Journal of basic and clinical physiology and pharmacology.
[599] S. Lipshultz,et al. Cardiovascular disease in long-term survivors of pediatric Hodgkin's disease , 1998 .
[600] G. Levitt,et al. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[601] J. Strong,et al. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[602] P. Rubin,et al. Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease. , 1996, International journal of radiation oncology, biology, physics.
[603] M. Siimes,et al. Myocardial function in children and adolescents after therapy with anthracyclines and chest irradiation. , 1996, European journal of cancer.
[604] J. Cunningham,et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. , 1995, The Journal of clinical endocrinology and metabolism.
[605] W. Oster,et al. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences. , 1995, European journal of cancer.
[606] R. Jenni,et al. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[607] D. Iarussi,et al. Protective effect of coenzyme Q10 on anthracyclines cardiotoxicity: control study in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma. , 1994, Molecular aspects of medicine.
[608] F. Ognibene,et al. High-Dose Ifosfamide Is Associated with Severe, Reversible Cardiac Dysfunction , 1993, Annals of Internal Medicine.
[609] N. Krinsky. Actions of carotenoids in biological systems. , 1993, Annual review of nutrition.
[610] H. Joensuu. Myocardial infarction after irradiation in Hodgkin's disease: a review. , 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[611] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[612] J. Himes. Anthropometric assessment of nutritional status , 1991 .
[613] K. Anderson,et al. Cardiovascular disease risk profiles. , 1991, American heart journal.
[614] S. Lipshultz,et al. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. , 1990, The Journal of pediatrics.
[615] D. Urbanová. The role of endomyocardial biopsy in the diagnosis and treatment of heart disease. , 1989, Acta Universitatis Carolinae. Medica.
[616] J. G. Miller,et al. Ultrasound integrated backscatter tissue characterization of remote myocardial infarction in human subjects. , 1989, Journal of the American College of Cardiology.
[617] Y. Kaneko,et al. Possible association of human growth hormone treatment with an occurrence of acute myeloblastic leukemia with an inversion of chromosome 3 in a child of pituitary dwarfism. , 1988, Medical and pediatric oncology.
[618] L. F. Fajardo,et al. Vascular lesions following radiation. , 1988, Pathology annual.
[619] W. Roberts,et al. Coronary heart disease after mediastinal irradiation for Hodgkin's disease. , 1976, The American journal of medicine.
[620] L. F. Fajardo,et al. Radiation-induced heart disease. Clinical and experimental aspects. , 1971, Radiologic clinics of North America.
[621] L. F. Fajardo,et al. Morphology of radiation-induced heart disease. , 1968, Archives of pathology.
[622] E. Antman,et al. Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .